Diabetes

Atrasentan tied to lower risk for kidney events in T2DM with CKD

(HealthDay)—Atrasentan is associated with a reduced risk for renal events in patients with type 2 diabetes and chronic kidney disease, according to a study published online April 14 in The Lancet to coincide with the International ...

HIV & AIDS

Naltrexone implant helps HIV patients prevent opioid relapse

(HealthDay)—Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.

Psychology & Psychiatry

Group, telephone, guided CBT treatment effective for depression

(HealthDay)—Group, telephone, and guided self-help cognitive behavioral therapy (CBT) formats are as effective as individual CBT for adult depression, according to research published online April 17 in JAMA Psychiatry.

page 1 from 12